Sigilon Therapeutics, Inc.

SGTX · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$42,066$107,143$202,229$76,069
Short-Term Investments$27,560$16,213$0$0
Receivables$3,458$59$177$136
Inventory$250$250$75$0
Other Curr. Assets$1,077$2,729$1,729$732
Total Curr. Assets$74,411$126,394$204,210$76,937
Property Plant & Equip (Net)$11,833$16,857$19,722$12,800
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,034$1,118$1,118$641
Total NC Assets$12,867$17,975$20,840$13,441
Other Assets$0$0$0$0
Total Assets$87,278$144,369$225,050$90,378
Liabilities
Payables$936$2,344$1,988$2,005
Short-Term Debt$11,152$6,512$5,361$3,378
Tax Payable$0$0$0$0
Deferred Revenue$12,885$17,034$31,777$29,140
Other Curr. Liab.$6,021$8,998$7,892$5,852
Total Curr. Liab.$30,994$34,888$47,018$40,375
LT Debt$16,909$26,988$31,700$21,676
Deferred Rev, NC$0$5,333$0$15,550
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$233$0$176$90,539
Total NC Liab.$17,142$32,321$31,876$127,765
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$48,136$67,209$78,894$168,140
Equity
Pref Stock$0$0$225,050$0
Common Stock$32$32$31$5
Retained Earnings-$256,800-$213,239-$135,928-$81,320
AOCI-$429-$10-$225,050$0
Other Equity$296,339$290,377$282,053$3,553
Total Equity$39,142$77,160$146,156-$77,762
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$87,278$144,369$225,050$90,378
Net Debt-$14,005-$73,643-$165,168-$51,015